Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it ...

周二，杰富瑞修改了对GlaxoSmithKline (GSK:LN) (NYSE: GSK)股票的立场，将这家制药巨头的评级从"买入"下调至"持有"。该公司还将目标价从此前的INR 20.00调整至INR 15.25。此次下调是由于预期该公司在2025年的增长将受到抑制，受到多种挑战的影响。

Proton pump inhibitors (PPIs) are widely used medications to manage common digestive issues like heartburn, acid reflux, and ...

Donald Trump returning to the White House triggered new index records in the US, and major UK companies are likely to feel ...

Donald Trump urged Vladimir Putin not to escalate the war in Ukraine in a phone call two days after the presidential election, according to reports - but the Kremlin says this isn't true.

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks. Now they're getting on his nerves. The post These 2 former stock market darlings ...

在第七届中国国际进口博览会，葛兰素史克（GSK）携多款重磅疫苗参展。同时，企业还主办了“深化医防融合，共筑健康中国”主题圆桌论坛，积极探索医防融合创新模式，为推动我国疫苗预防体系建设贡献力量。